MSOS News

Post date: 2 months 2 weeks ago

Drug diversion can involve high-value non-controlled medications, such as those used to treat cancer or symptoms of opioid use. This week’s featured article provides recommendations for incorporating medications beyond controlled substances in diversion response programs: https://www.ismp.org/node/126033

Post date: 2 months 4 weeks ago

ISMP is accepting applications for the FDA/ISMP Safe Medication Management Fellowship that begins this summer! Fellows spend six months each with ISMP and the FDA to gain valuable regulatory experience and learn current approaches to error prevention. Application deadline is March 29, 2024: https://www.ismp.org/professional-development/fellowships

Post date: 3 months 4 days ago

ISMP has released its updated list of consensus-based Best Practices, which includes new recommendations on tranexamic acid, vaccines, and transitions in care: www.ismp.org/node/160/. We encourage hospitals and health systems to incorporate them into their medication safety efforts and also to participate in a brief survey measuring current implementation of the new practices by April 19, 2024: https://surveys.ismp.org/s3/ISMP-Survey-on-the-Three-NEW-2024-2025-Targe...

Post date: 3 months 2 weeks ago

The phrase “protect from light” is often poorly defined. This week’s featured newsletter article provides insights and safe practice recommendations: www.ismp.org/node/121525

Post date: 4 months 2 days ago

This week’s ISMP featured newsletter article warns about online merchandise that looks like real medications, sometimes with a scannable barcode. For safe practice recommendations to help avoid potential for drug diversion and risk of patient harm: www.ismp.org/node/119273

Pages